Pyridine → HCID 15583553, compound
Reaction equation
[OH:1][CH2:2][CH2:3][O:4][CH:5]([N:15]1[CH:22]=[C:21]([F:23])[C:19](=[O:20])[NH:18][C:16]1=[O:17])[C:6]1[CH:11]=[CH:10][C:9]2[O:12][CH2:13][O:14][C:8]=2[CH:7]=1.N1C=CC=CC=1.[C:30](OC(=O)C)(=[O:32])[CH3:31]>>[C:30]([O:1][CH2:2][CH2:3][O:4][CH:5]([N:15]1[CH:22]=[C:21]([F:23])[C:19](=[O:20])[NH:18][C:16]1=[O:17])[C:6]1[CH:11]=[CH:10][C:9]2[O:12][CH2:13][O:14][C:8]=2[CH:7]=1)(=[O:32])[CH3:31]Participants
4
Procedure
1-[α-(2-Hydroxyethoxy)-3,4-methylendioxybenzyl]-5-fluorouracil obtained in Example 10 was dissolved in acetic anhydride (20 ml) and pyridine (20 ml) followed by stirring at room temperature for 3 hours. The reaction mixture was poured into ice-water and the resulting oil was extracted with chloroform (100 ml). The extract was washed with hydrochloric acid and then water, dried over magnesium sulfate and evaporated under reduced pressure to remove chloroform. The residue was treated with ligroinacetone to give 4.3 g of crystalline 1-[α-(2-acetoxyethoxy)-3,4-methylenedioxybenzyl]-5-fluorouracil.
Workup
- extractionthe resulting oil was extracted with chloroform (100 ml)
- washThe extract was washed with hydrochloric acid
- dry with materialwater, dried over magnesium sulfate
- customevaporated under reduced pressure
- customto remove chloroform
- additionThe residue was treated with ligroinacetone
Sources & evidence
- ORD record
- ord-96b7a049baf544cdb6b089ae016f1814
- Source dataset
- uspto-grants-1983_11
- Patent number
- US04415573
Reaction notes
Loading…